Jim Mish spent over 30 years in the specialty chemical industry in executive leadership positions at both privately-held and publicly-traded companies. He joined the Noramco team from Ashland where he held the role of President of Global Consumer Specialties, a leading global provider of pharmaceutical, personal care, and nutritional specialty ingredients. Previously, he served as Senior Vice President of Personal Care and Pharmaceutical Ingredients at International Specialty Products (ISP), which was acquired by Ashland in 2011. Jim began his career at Pfizer Pharmaceutical in research and development before holding positions of increasing responsibility at Imperial Chemical Industries (ICI), ARCO Chemical, Penn Specialty Chemicals and National Starch.
Alan manages the day-to-day and long-term operational and financial responsibilities for Noramco. Before joining the company in September of 2017, Alan served as the Executive Vice President of Nippon Steel and Sumitomo Metal Corporation’s Standard Steel subsidiary, where he held broad operational and financial responsibilities. He previously served as Standard Steel’s Chief Financial Officer, where he successfully guided the Company through two private equity ownership cycles. In 2011, Alan managed the sale of Standard Steel to Sumitomo Metal Industries and Sumitomo Corporation. Alan began his career in the PricewaterhouseCoopers Pittsburgh audit practice from 1994-1999. He received an Alumni Achievement Award from The Pennsylvania State University in 2007, and in 2006 was awarded “CFO of the Year” by the Pittsburgh Business Times in the large private company category. Alan holds an MBA from The Pennsylvania State University’s Smeal College of Business Administration, and a B.S. in Accounting from Grove City College.
Charlie Enzinger, Senior Vice President, Integrated Supply Chain, joined the team from Univar, where he was responsible for leading the company’s supply chain transformation initiatives. Throughout his career, he has held executive roles at leading industrial and specialty chemical companies, including Nalco and DuPont where he specialized in leading turnaround initiatives such as improving underperforming supply chain and plant operations. Mr. Enzinger is trained in Six Sigma, Lean Enterprise and Theory of Constraints.
Bill Grubb, Vice President, Business Development and Innovation, oversees all aspects of Noramco’s strategic growth and innovation functions, including acquisitions, partnerships, and new product development platforms. Bill is integral to advancing and diversifying the portfolio of products, developing fast-track processes to move upstream R&D through stage gates, to FDA filings, and to the supply chain. As part of his responsibilities, he also leads the strategic planning, pricing, marketing & external communications functions for Noramco. Joining Noramco in 1997, Bill brings a unique perspective to the role, having spent equal time in development, operations, and commercial leadership positions. Bill led the global team that developed, filed, and launched 10 of the products that make-up the core Noramco product line today, and before his current role, led the global commercial team. He has a 25+ year proven track record of success in the branded drug and generic API industry, working for Burroughs-Welcome, Glaxo, and Johnson & Johnson. Bill holds a degree in Chemistry and Physics and a strategic management certificate from Northwestern’s Kellogg School of Management.
Jan Henk oversees all commercial aspects of Noramco globally and all activity for both the EMEA and Asia regions. He brings a wealth of experience of more than twenty years in specialty chemicals and performance ingredients. Jan Henk started with Unilever and spent most of his career with National Starch and Chemical Company, ISP and Ashland. He started in manufacturing and later held several sales and business leadership roles in a variety of markets, most notably personal care, nutrition and pharmaceutical excipients. He has been based in many different countries, but predominantly in Switzerland, the United States, China, Italy and Germany. Jan Henk holds a MSc degree in chemical engineering and an MBA in general and strategic management.
Scott Warner, Vice President & General Counsel, is the Chief legal officer managing the day-to-day legal support for Noramco, responsible for aligning the legal function with strategic business goals. Scott is a solutions oriented business attorney adept at managing risk while facilitating rapid corporate growth. He is an expert in complex legal issues with a proven track record of driving negotiations to the desired outcome, and has deep experience in joint ventures, mergers and acquisitions, compliance and data privacy, insurance, and intellectual property. Prior to joining Noramco, Scott was General Counsel for a private-equity owned CDMO with nearly 1000 employees operating out of seven sites in the US and Europe. Before going in-house, he spent many years in private practice. In 1995, Scott was appointed by President Clinton as one of three U.S. representatives on a four-year joint diplomatic committee, successfully resolving issues for the transfer of control of the Canal from the US to Panama. In November 2013, Scott completed the 140.6 mile Florida Ironman. In addition to his law degree, Scott has an MBA in finance.
Brian Dillion leads the global Quality Assurance, Regulatory Affairs, and Compliance teams for Noramco. He oversees all quality assurance and quality control activities that ensure best-in-class manufacture of regulated active pharmaceutical ingredients (APIs) and manages the quality and compliance activities that ensure the company’s contract manufacturing organization (CMO) network maintains the highest standard of quality. Brian also manages regulatory affairs and related activities in support of regulatory filings, and approval of Noramco products, and works with clients on regulatory strategy in support of customers’ finished dosage forms. He is an expert in pharmaceutical quality, with a 25-year proven track record of success in upholding the world’s highest standards in sterile product manufacturing, solid oral dosage manufacturing, and API manufacturing for a major CMO. Before joining Noramco in 2017, he was VP, Quality & Regulatory for a leading global pharmaceutical contract manufacturer. Brian holds a B.A. in Chemistry from Carson-Newman College and an M.B.A. from the University of North Carolina – Wilmington.